GPR17 and asthma: Interestingly, the defective differentiation of OPCs isolated from the spinal cord of the SOD1G93A mutant mice was rescued by treatment with the GPR17 antagonist montelukast (a leukotrien receptor antagonist authorized for the management of asthma).